Long-Term Treatment with Amiodarone for the Prevention of Sudden Death in Patients with Dilated Cardiomyopathy
There is considerable controversy about the treatment of asymptomatic ventricular arrhythmias in patients with congestive heart failure . Antiarrhythmic therapy has been reported either to prolong survival and decrease the incidence of sudden death (SD) , or only to reduce mortality . Patients with dilated cardiomyopathy (DC) and complex ventricular arrhythmias have been treated successfully with amiodarone and no patient has died suddenly during therapy . Others have underlined that the evidence for results is still lacking . We report the results of our study on the efficacy of amiodarone for the prevention of SD in patients with DC and ventricular tachycardia (VT).
KeywordsToxicity Cardiomyopathy Cardiol Hypothyroidism Amiodarone
Unable to display preview. Download preview PDF.
- 3.Dargie HJ, Cleland JGF, Leckie BJ, Inglis CG, East BW, Ford I (1987) Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation [Suppl 4]: 98–107Google Scholar
- 7.Feigenbaum H (1986) Echocardiography, 4th edn. Lea and Febiger, PhiladelphiaGoogle Scholar
- 8.Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner ER, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 51: 507–512Google Scholar